Breathing variability during propofol/remifentanil procedural sedation with a single additional dose of midazolam or s-ketamine: a prospective observational study

Autor: S A Loer, O F C van den Bosch, K Delfsma, S G Schet, Ricardo Alvarez-Jimenez
Přispěvatelé: Anesthesiology, AII - Infectious diseases, ACS - Diabetes & metabolism
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Journal of Clinical Monitoring and Computing, 36(4), 1219-1225. Springer Netherlands
van den Bosch, OFC, Alvarez Jimenez, R, Delfsma, K, Schet, S G & Loer, SA 2022, ' Breathing variability during propofol/remifentanil procedural sedation with a single additional dose of midazolam or s-ketamine: a prospective observational study ', Journal of Clinical Monitoring and Computing, vol. 36, no. 4, pp. 1219-1225 . https://doi.org/10.1007/s10877-021-00773-2
ISSN: 1387-1307
DOI: 10.1007/s10877-021-00773-2
Popis: Purpose Regulation of spontaneous breathing is highly complex and may be influenced by drugs administered during the perioperative period. Because of their different pharmacological properties we hypothesized that midazolam and s-ketamine exert different effects on the variability of minute ventilation (MV), tidal volume (TV) and respiratory rate (RR). Methods Patients undergoing procedural sedation (PSA) with propofol and remifentanil received a single dose of midazolam (1–3 mg, n = 10) or s-ketamine (10–25 mg, n = 10). We used non-invasive impedance-based respiratory volume monitoring to record RR as well as changes in TV and MV. Variability of these three parameters was calculated as coefficients of variation. Results TV and MV decreased during PSA to a comparable extent in both groups, whereas there was no significant change in RR. In line with our hypothesis we observed marked differences in breathing variability. The variability of MV (– 47.5% ± 24.8%, p = 0.011), TV (– 42.1% ± 30.2%, p = 0.003), and RR (– 28.5% ± 29.3%, p = 0.011) was significantly reduced in patients receiving midazolam. In contrast, variability remained unchanged in patients receiving s-ketamine (MV + 16% ± 45.2%, p = 0.182; TV +12% ± 47.7%, p = 0.390; RR +39% ± 65.2%, p = 0.129). After termination of PSA breathing variables returned to baseline values. Conclusions While midazolam reduces respiratory variability in spontaneously breathing patients undergoing procedural sedation, s-ketamine preserves variability suggesting different effects on the regulation of spontaneous breathing.
Databáze: OpenAIRE
Externí odkaz: